Clinical Trials for Gliomas Harboring IDH1 and/or IDH2 Mutations

Find clinical trials for gliomas harboring idh1 and/or idh2 mutations. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations

NCT ID: NCT07025018

This clinical trial is studying a new medicine called HMPL-306 to treat a type of brain tumor known as gliomas, specifically those with certain genetic changes called IDH1 and IDH2 mutations. The m...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions